BioCardia’s CardiAMP cleared Japan’s PMDA consultation - a first for catheter-delivered cardiac cell therapy.
China’s NMPA approved golimumab biosimilar ASHULI as the first in China, completing Bio-Thera’s unprecedented US-EU-China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results